Europe’s tentative embrace of agricultural gene editing could revolutionize food production and health in Asia

Credit: Lê Tuấn Hùng  via CC0-1.0
Credit: Lê Tuấn Hùng via CC0-1.0

On June 17, 2026, the European Parliament reached a historic milestone by endorsing New Genomic Techniques (NGTs), sending a powerful global signal that science-based innovation is essential for addressing climate change and strengthening food security.

For Asia, the implications could be profound.

Home to nearly 60% of the world’s population, Asia faces the daunting task of feeding billions while confronting some of the world’s harshest climate impacts. 

Rising temperatures, droughts, floods, salinity intrusion, emerging pests, and global crises are placing immense pressure on agricultural systems. 

According to the International Food Policy Research Institute (IFPRI), countries such as Bangladesh, India, and Pakistan remain highly vulnerable to geopolitical shocks because of their dependence on imported fertilizers and natural gas from the Gulf region. The ongoing Iran conflict, the latest disruption to global fertilizer markets, underscores this vulnerability.

Against this backdrop, NGTs offer a promising tool for developing climate-resilient crops, reducing reliance on pesticides and fertilizers, and strengthening food security, particularly for smallholder farmers.

Mis- and disinformation are distorting science and public policy. Subscribe to our Daily and Weekly Digests for incisive coverage of ‘disruptive’ innovations in AI, agricultural biotechnology, food, chemicals, nuclear energy, vaccines, and other disruptive innovations.

For decades, the European Union maintained some of the world’s strictest regulations on agricultural biotechnology, influencing policy-making far beyond Europe. Many countries in Asia and Africa adopted similarly cautious approaches. 

Europe’s endorsement of NGTs therefore marks a significant shift, demonstrating that innovation and environmental sustainability can go hand in hand.

Several Asian countries are already moving ahead. China has made gene editing a national priority to enhance food security, while Japan has established enabling regulations and commercialized gene-edited foods. 

India is actively exploring genome editing to develop climate-resilient crops, and countries including the Philippines, South Korea, Singapore, Vietnam, and Bangladesh are advancing research and regulatory reforms.

Yet technological potential alone will not be enough. Historically, biotechnology research has relied heavily on private investment and donor support. 

Today, shrinking research budgets, limited technical expertise, and underinvestment in public research institutions remain major constraints, particularly in developing countries. 

Realizing the benefits of genome editing will require evidence-based policymaking, sustained public investment, and long-term government commitment to translate scientific advances into practical solutions for farmers.

Europe’s decision should not be treated as a blueprint to be followed uncritically. Rather, it should encourage countries such as Bangladesh to engage in evidence-based decision-making and assess how emerging technologies like genome editing can contribute to more resilient, sustainable, and food-secure agricultural systems.

Arif Hossain is Regional Head of Asia, WePlanet International and Executive Director at Farming Future Bangladesh. Find Arif on X @arif4science

A version of this article was originally posted at Dhaka Tribune and has been reposted here with permission. Any reposting should credit the original author and provide links to both the GLP and the original article. Find Dhaka Tribune on X @DhakaTribune



Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Personalized-Cancer-mRNA-Vaccine-Vial
Personalized mRNA vaccines are poised to revolutionize cancer treatments. Here are the barriers.
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
Screenshot-2026-09-22-at-12.26.15-PM
‘Forever chemical’ concerns: Separating hysteria from reasonable concern in the debate over PFAS danger
Screenshot-2026-10-11-at-10.24.21-AM
Viewpoint: RFK Jr.’s new CDC head Erica Schwartz greenlights hepatitis B vaccine study critics call “unethical and designed to cast doubts on its safety”
Screenshot-2026-10-05-at-11.57.44-AM
Scaremongering or legitimate safety concerns? The political dogfight over America’s food safety system
Deepfake Democracy Media Mosaic
31 states have passed a patchwork of laws to limit election deepfake commercials. They’re not working very well.
Screenshot 2026-10-12 at 12.25
Tearful onions? CRISPR has a solution for that
Screenshot-2026-10-08-at-1.23.28-PM
Countries around the world are rushing to pass teenage social media bans. Could they backfire?
AI-Force-Uniform-Insignia-Close-Up
Trump wants an AI Force like Space Force, but that could make AI’s risks harder to manage
AI Doctor with a Digital Neural Head
Utah becomes first state to empower AI to bypass doctors and prescribe certain drugs
Radioactive-Americana-Collage-2
The kooky logic behind the raft of spurious cancer claims from Harvard’s T.H. Chan School of Public Health
generated-1790707585414
Facts & Fallacies podcast: America's health care system is broken. A doctor explains how to fix it
Screenshot-2026-09-22-at-10.54.12-AM
‘They misunderstand science’: Research attempting to tie autism to changes in the gut microbiome comes under fire
Concerned-Farmer-at-Golden-Hour
GAHA: The corporate-created “healthier America” movement challenging what it claims is MAHA misinformation about modern farming, chemicals, and food
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.